Shanghai Government officially recommends Vitamin C for COVID-19

The government of Shanghai, China has announced its official recommendation that COVID-19 should be treated with high amounts of intravenous vitamin C. (1) Dosage recommendations vary with severity of illness, from 50 to 200 milligrams per kilogram body weight per day to as much as 200 mg/kg/day. 

These dosages are approximately 4,000 to 16,000 mg for an adult, administered by IV. This specific method of administration is important, says intravenous therapy expert Atsuo Yanagisawa, MD, PhD, because vitamin C's effect is at least ten times more powerful by IV than if taken orally. Dr. Yanagisawa is president of the Tokyo-based Japanese College of Intravenous Therapy. He says, "Intravenous vitamin C is a safe, effective, and broad-spectrum antiviral." 

Richard Z. Cheng, MD, PhD, a Chinese-American specialist physician, has been working closely with medical and governmental authorities throughout China. He has been instrumental in facilitating at least three Chinese clinical IV vitamin C studies now underway. Dr. Cheng is presently in Shanghai continuing his efforts to encourage still more Chinese hospitals to implement vitamin C therapy incorporating high oral doses as well as C by IV. 

Dr. Cheng and Dr. Yanagisawa both recommend oral vitamin C for prevention of COVID-19 infection. 

An official statement from Xi'an Jiaotong University Second Hospital (2) reads: 

"On the afternoon of February 20, 2020, another 4 patients with severe new coronaviral pneumonia recovered from the C10 West Ward of Tongji Hospital. In the past 8 patients have been discharged from hospital. . . [H]igh-dose vitamin C achieved good results in clinical applications. We believe that for patients with severe neonatal pneumonia and critically ill patients, vitamin C treatment should be initiated as soon as possible after admission. . .[E]arly application of large doses of vitamin C can have a strong antioxidant effect, reduce inflammatory responses, and improve endothelial function. . . Numerous studies have shown that the dose of vitamin C has a lot to do with the effect of treatment. . . [H]gh-dose vitamin C can not only improve antiviral levels, but more importantly, can prevent and treat acute lung injury (ALI) and acute respiratory distress (ARDS)."

For more information, below is a list of previous reporting by OMNS on COVID-19 and vitamin C:

 

Mar 1, 2020News Media Attacks Vitamin C Treatment of COVID-19 Coronavirus

Feb 28, 2020Vitamin C and COVID-19 Coronavirus

Feb 23, 2020TONS OF VITAMIN C TO WUHAN: China Using Vitamin C against COVID

Feb 21, 2020Three Intravenous Vitamin C Research Studies Approved for Treating COVID-19

Feb 16, 2020Early Large Dose Intravenous Vitamin C is the Treatment of Choice for 2019-nCov Pneumonia

Feb 13, 2020Coronavirus Patients in China to be Treated with High-Dose Vitamin C

Feb 10, 2020VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS: How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases

Feb 2, 2020Hospital-based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses

Jan 30, 2020Nutritional Treatment of Coronavirus

Jan 26, 2020Vitamin C Protects Against Coronavirus

References

1. https://mp.weixin.qq.com/s/bF2YhJKiOfe1yimBc4XwOA

2. http://2yuan.xjtu.edu.cn/Html/News/Articles/21774.html

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Ilyès Baghli, M.D. (Algeria) 
Ian Brighthope, MBBS, FACNEM (Australia) 
Prof. Gilbert Henri Crussol (Spain) 
Carolyn Dean, M.D., N.D. (USA) 
Damien Downing, M.D. (United Kingdom) 
Michael Ellis, M.D. (Australia) 
Martin P. Gallagher, M.D., D.C. (USA) 
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico) 
William B. Grant, Ph.D. (USA) 
Tonya S. Heyman, M.D. (USA) 
Suzanne Humphries, M.D. (USA) 
Ron Hunninghake, M.D. (USA) 
Robert E. Jenkins, D.C. (USA) 
Bo H. Jonsson, M.D., Ph.D. (Sweden) 
Jeffrey J. Kotulski, D.O. (USA) 
Peter H. Lauda, M.D. (Austria) 
Thomas Levy, M.D., J.D. (USA) 
Homer Lim, M.D. (Philippines) 
Stuart Lindsey, Pharm.D. (USA) 
Victor A. Marcial-Vega, M.D. (Puerto Rico) 
Charles C. Mary, Jr., M.D. (USA) 
Mignonne Mary, M.D. (USA) 
Jun Matsuyama, M.D., Ph.D. (Japan)  
Dave McCarthy, M.D. (USA) 
Joseph Mercola, D.O. (USA) 
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico) 
Karin Munsterhjelm-Ahumada, M.D. (Finland) 
Tahar Naili, M.D. (Algeria) 
W. Todd Penberthy, Ph.D. (USA) 
Dag Viljen Poleszynski, Ph.D. (Norway) 
Selvam Rengasamy, MBBS, FRCOG (Malaysia) 
Jeffrey A. Ruterbusch, D.O. (USA) 
Gert E. Schuitemaker, Ph.D. (Netherlands) 
Hyoungjoo Shin, M.D. (South Korea) 
Thomas L. Taxman, M.D. (USA) 
Jagan Nathan Vamanan, M.D. (India) 
Garry Vickar, MD (USA) 
Ken Walker, M.D. (Canada) 
Anne Zauderer, D.C. (USA)

Andrew W. Saul, Ph.D. (USA), Editor-In-Chief 
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan) 
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA) 
Robert G. Smith, Ph.D. (USA), Associate Editor 
Helen Saul Case, M.S. (USA), Assistant Editor 
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor 
Jason M. Saul, JD (USA), Legal Consultant

Comments and media contact: [email protected]octoryourself.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.

This news release was sent to [email protected]. If you no longer wish to receive news releases, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: unsubscribe . To update your profile settings click here . 

This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.

REGISTER NOW

By Andrew W. Saul, PhD / Editor-in-Chief of the Orthomolecular Medicine News Service

Andrew W. Saul is Editor-in-Chief of the Orthomolecular Medicine News Service, now in its 15th year of free publication. He is also a member of the Japanese College of Intravenous Therapy, the Orthomolecular Medicine Hall of Fame, and is author or coauthor of twelve books. He has no financial connection whatsoever to the supplement or health products industry.

(Source: orthomolecular.activehosted.com; March 3, 2020; https://is.gd/AJwhpB)
Back to INF

Loading please wait...